Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Evercore ISI Group Downgrades Ciena to In-Line

Evercore ISI Group Downgrades Ciena to In-Line

Evercore ISI Group analyst Amit Daryanani downgrades Ciena (NYSE:CIEN) from Outperform to In-Line.

byBenzinga Newsdesk

October 11, 2022

1 minute read

Evercore ISI Group analyst Amit Daryanani downgrades Ciena (NYSE:CIEN) from Outperform to In-Line.

Netflix, Home Depot And More On CNBC’s ‘Final Trades’

By Avi Kapoor

May 6, 8:46 AM

Los Gatos, California-based Netflix reported earnings per share of $5.28 for the quarter, which beat a Street consensus estimate of $4.51.

GOOGL

Barclays Maintains Overweight on Axalta Coating Sys, Lowers Price Target to $31

By Benzinga Newsdesk

July 11, 9:36 AM

Barclays analyst Michael Leithead maintains Axalta Coating Sys (NYSE:AXTA) with a Overweight and lowers the price target from $34 to $31.

AXTA

News

Celebrity Cruises Launches The World’s First Digital Cruise Ship Experience In The Metaverse

By Benzinga Newsdesk

December 14, 10:08 AM

In a groundbreaking industry-first, travelers can now immerse themselves with a Celebrity ship before they ever set sail in the brand's all-new, 'Wonderverse.' Visitors can also explore and book vacation

RCL

News

Cidara Therapeutics Granted U.S. Patent #11510992: Compositions and methods for the treatment of viral infections

By Charles Gross

November 29, 2:52 PM

https://www.scribd.com/document/611131671/CDTX-Patent

CDTX

Evercore ISI Group Downgrades Ciena to In-Line

Related Posts

Netflix, Home Depot And More On CNBC’s ‘Final Trades’

Barclays Maintains Overweight on Axalta Coating Sys, Lowers Price Target to $31

Celebrity Cruises Launches The World’s First Digital Cruise Ship Experience In The Metaverse

Cidara Therapeutics Granted U.S. Patent #11510992: Compositions and methods for the treatment of viral infections